TNFRSF11B and malignant colon neoplasm: In our cohort, 72.09% (62/86) of the colon cancer patients who received radical surgery had TNFRSF11B overexpression, which was associated with significantly shorter overall survival times (p = 0.072, Figures 3A, B).